BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16160174)

  • 21. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle.
    Enssle J; Fischer N; Moebes A; Mauer B; Smola U; Rethwilm A
    J Virol; 1997 Oct; 71(10):7312-7. PubMed ID: 9311808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cooperative function of arginine residues in the Prototype Foamy Virus Gag C-terminus mediates viral and cellular RNA encapsidation.
    Hamann MV; Müllers E; Reh J; Stanke N; Effantin G; Weissenhorn W; Lindemann D
    Retrovirology; 2014 Oct; 11():87. PubMed ID: 25292281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-terminally myristoylated feline foamy virus Gag allows Env-independent budding of sub-viral particles.
    Liu Y; Kim YB; Löchelt M
    Viruses; 2011 Nov; 3(11):2223-37. PubMed ID: 22163342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Particle assembly and genome packaging.
    Linial ML; Eastman SW
    Curr Top Microbiol Immunol; 2003; 277():89-110. PubMed ID: 12908769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of gag mutations on human immunodeficiency virus type 1 particle assembly, processing, and cyclophilin A incorporation.
    Chiu HC; Wang FD; Yao SY; Wang CT
    J Med Virol; 2002 Oct; 68(2):156-63. PubMed ID: 12210402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein composition and morphology of human foamy virus intracellular cores and extracellular particles.
    Morozov VA; Copeland TD; Nagashima K; Gonda MA; Oroszlan S
    Virology; 1997 Feb; 228(2):307-17. PubMed ID: 9123838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis and function of prototype foamy virus envelope N glycosylation.
    Lüftenegger D; Picard-Maureau M; Stanke N; Rethwilm A; Lindemann D
    J Virol; 2005 Jun; 79(12):7664-72. PubMed ID: 15919919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bet gene of feline foamy virus is required for virus replication.
    Alke A; Schwantes A; Kido K; Flötenmeyer M; Flügel RM; Löchelt M
    Virology; 2001 Sep; 287(2):310-20. PubMed ID: 11531409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
    Blanchet M; Sureau C
    J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid.
    Goldstone DC; Flower TG; Ball NJ; Sanz-Ramos M; Yap MW; Ogrodowicz RW; Stanke N; Reh J; Lindemann D; Stoye JP; Taylor IA
    PLoS Pathog; 2013 May; 9(5):e1003376. PubMed ID: 23675305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in capsid major homology region affect assembly and membrane affinity of HIV-1 Gag.
    Chang YF; Wang SM; Huang KJ; Wang CT
    J Mol Biol; 2007 Jul; 370(3):585-97. PubMed ID: 17532005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis.
    Müllers E; Uhlig T; Stirnnagel K; Fiebig U; Zentgraf H; Lindemann D
    J Virol; 2011 Feb; 85(4):1452-63. PubMed ID: 21106749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional analysis of brome mosaic virus coat protein RNA-interacting domains.
    Calhoun SL; Rao AL
    Arch Virol; 2008; 153(2):231-45. PubMed ID: 18066637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opposing effects of the M368A point mutation and deletion of the SP1 region on membrane binding of human immunodeficiency virus type 1 Gag.
    Guo X; Liang C
    Virology; 2005 May; 335(2):232-41. PubMed ID: 15840522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the relative amounts of Gag and Pol proteins in foamy virus particles.
    Cartellieri M; Rudolph W; Herchenröder O; Lindemann D; Rethwilm A
    Retrovirology; 2005 Jul; 2():44. PubMed ID: 16004609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression.
    Stenbak CR; Linial ML
    J Virol; 2004 Sep; 78(17):9423-30. PubMed ID: 15308736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.
    Scheifele LZ; Kenney SP; Cairns TM; Craven RC; Parent LJ
    J Virol; 2007 Oct; 81(19):10718-28. PubMed ID: 17634229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of a Spumaretrovirus Gag Central Domain Reveals an Ancient Retroviral Capsid.
    Ball NJ; Nicastro G; Dutta M; Pollard DJ; Goldstone DC; Sanz-Ramos M; Ramos A; Müllers E; Stirnnagel K; Stanke N; Lindemann D; Stoye JP; Taylor WR; Rosenthal PB; Taylor IA
    PLoS Pathog; 2016 Nov; 12(11):e1005981. PubMed ID: 27829070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.